SCHEDULE 13D/A Filed 2026-05-21 Event 2026-05-19 SEC 0001231919-26-000523 →

Frazier Life Sciences Public Fund, L.P. → KalVista Pharmaceuticals, Inc.

Stake: 2.30% Shares: 1,249,165 CUSIP: 483497103 Class: Common Stock, $0.001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

7 transactions

0 buys · 3 sales · 4 awards/exercises

Issuer Cluster

10 13D/G filings on this issuer

9 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $36.88M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-17	Palleiko Benjamin L	director, officer	Sale	9,550	$20.22	$193K
2026-04-17	Piekos Brian	officer	Sale	1,862	$20.22	$38K
2026-04-17	Sweeny Nicole	officer	Sale	1,862	$20.22	$38K
2026-04-16	Piekos Brian	officer	Option exercise	6,250	—	—
2026-04-16	Audhya Paul K.	officer	Option exercise	6,250	—	—
2026-04-16	Sweeny Nicole	officer	Option exercise	6,250	—	—
2026-04-16	Palleiko Benjamin L	director, officer	Option exercise	20,312	—	—

Other 13D/G Filings on KalVista Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-10	SCHEDULE 13G	GLAZER CAPITAL, LLC	—	—	view →
2024-04-01	SC	TCG Crossover GP I, LLC	—	—	view →
2024-02-20	SC	TCG Crossover GP I, LLC	—	—	view →
2022-02-10	SC	Longwood Fund II, L.P.	—	—	view →
2021-02-16	SC	SVLSF IV, LLC	—	—	view →
2019-04-24	SC	RA CAPITAL MANAGEMENT, LLC	—	—	view →
2019-04-15	SC	RA CAPITAL MANAGEMENT, LLC	—	—	view →
2019-04-03	SC	SVLSF IV, LLC	—	—	view →
2019-03-20	SC	SVLSF IV, LLC	—	—	view →

Other Filings by Frazier Life Sciences Public Fund, L.P.

Filed	Form	Issuer	Stake	Shares
2026-08-11	SCHEDULE 13D	Attovia Therapeutics, Inc.	13.50%	760,327	view →
2026-08-10	SCHEDULE 13D/A	MBX BIOSCIENCES, INC.	—	1,429,573	view →
2025-09-30	SCHEDULE	MBX Biosciences, Inc. MBX	11.70%	5,224,095	view →
2025-09-17	SCHEDULE	HilleVax, Inc.	—	—	view →
2023-09-27	SC	HilleVax, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →